Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- The 109th Annual Meeting of Japan Ophthalmological Society
April 18, 2005
- Kibanken Starts Up with Staff of 95
April 18, 2005
- Kyoto Univ. Hospital to Beef Up New Drug Development
April 18, 2005
- Huma Aims to Boost Registered Volunteers to 500,000
April 18, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 18, 2005
- Roche's Anticancer Agent Tarceva Approved in Switzerland
April 11, 2005
- Amended PAL Goes into Full Effect
April 11, 2005
- Self-injection to Be Allowed for INF a, Etanercept
April 11, 2005
- DIAGNOSTIC NEWS IN BRIEF
April 11, 2005
- Council for Unapproved Drugs Examines Natalizumab, Bortezumib
April 11, 2005
- Chuikyo Approves Listing of 3 Drugs Including Oxaliplatin
April 11, 2005
- Study Group on Clinical Trials Holds 1st Meeting
April 11, 2005
- MREAC Finalizes Activities Plan for FY2005
April 11, 2005
- Pfizer Japan Maintains Lead in MR Calls: MOSS Institute
April 11, 2005
- Rules on Sale of Ethical Drugs Clarified
April 11, 2005
- 1st 3Qtrs Business Results
April 11, 2005
- PMDA to Answer Complaints within 15 Days
April 11, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 11, 2005
- REGULATORY NEWS IN BRIEF
April 11, 2005
- The Reporter's Eye: 4
April 11, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…